HOWL
#4294
Werewolf Therapeutics, Inc. - Common Stock
0.9 4 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.09%
Monthly Change
+108.89%
6 month change
+62.07%
Year Change
-27.69%
Previous Close
0.9 7
Open
0.9 4
Low
0.9 4
High
0.9 4
Volume
14
Financials
- Market Capitalization 45.68 M
- Employee 14
- Founded 2017
- CEO N/A
- Website www.werewolftx.com
- Headquarter Delaware, United States
- FIGI BBG00QXQ9XK4
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.48
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4281 |  TCRX TScan Therapeutics, Inc. - Common Stock | 0.75 USD | 0.00% | -5.06% | -1.32% | -58.33% | 47.63 M USD | ||
| 4293 |  CELU Celularity Inc. - Class A Common Stock | 1.58 USD | -24.76% | +105.19% | +132.35% | -49.03% | 45.73 M USD | ||
| 4300 |  MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.19 USD | -1.65% | -4.80% | -0.83% | -17.36% | 44.95 M USD | ||
| 4302 |  TVGN Tevogen Bio Holdings Inc. - Common Stock | 6.89 USD | +1.92% | +6.99% | +12.58% | +657.14% | 44.86 M USD |
Frequently asked questions about Werewolf Therapeutics, Inc. Common Stock
What is the Werewolf Therapeutics, Inc. Common Stock stock price today?
The current price of Werewolf Therapeutics, Inc. Common Stock (HOWL) is 0.94. Over the past 24 hours, the stock has changed by -3.09%. Follow the HOWL chart for real-time price dynamics.
What is the stock ticker of Werewolf Therapeutics, Inc. Common Stock?
Werewolf Therapeutics, Inc. Common Stock trades under the ticker HOWL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Werewolf Therapeutics, Inc. Common Stock stock going up?
HOWL has changed by +10.59% over the last week, +108.89% over the last month, and -27.69% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Werewolf Therapeutics, Inc. Common Stock?
Werewolf Therapeutics, Inc. Common Stock currently has a market capitalization of 45.68 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Werewolf Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Werewolf Therapeutics, Inc. Common Stock reported earnings of 0.08 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Werewolf Therapeutics, Inc. Common Stock revenue for the last quarter?
Werewolf Therapeutics, Inc. Common Stock reported quarterly revenue of -3.35 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Werewolf Therapeutics, Inc. Common Stock net income for the last quarter?
Werewolf Therapeutics, Inc. Common Stock reported net income of 3.67 M for the last quarter. The previous quarter showed -13.53 M, which means net income changed by +127.12%.
How many employees does Werewolf Therapeutics, Inc. Common Stock have?
As of the latest available data, Werewolf Therapeutics, Inc. Common Stock has 14 employees. Workforce size can provide additional context about the company's scale and operations.
What is Werewolf Therapeutics, Inc. Common Stock EBITDA?
Werewolf Therapeutics, Inc. Common Stock EBITDA is -14.74 M, and its EBITDA margin is 439.59%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Werewolf Therapeutics, Inc. Common Stock stock?
You can buy Werewolf Therapeutics, Inc. Common Stock (HOWL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Werewolf Therapeutics, Inc. Common Stock stock?
Investing in Werewolf Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the HOWL chart and related analysis on metatrader.com as part of your research.